Table 1.
Characteristics before and after propensity score matching
| Variables | Before matching | After matching | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| GLP‐1RA (−) | GLP‐1RA (+) | Standardized difference | GLP‐1RA (−) | GLP‐1RA (+) | Standardized difference | |||||
| (n = 923) | (n = 205) | (n = 205) | (n = 205) | |||||||
| Age (years) | 72 | (63, 77) | 70 | (62, 76) | 0.088 | 72 | (64, 77) | 70 | (62, 76) | 0.099 |
| Sex (male) | 728 | (78.9) | 163 | (79.5) | 0.016 | 154 | (75.1) | 163 | (79.5) | 0.105 |
| HbA1c (%) | 7.0 | (6.6, 7.5) | 7.3 | (6.8, 7.8) | 0.258 | 7.3 | (6.8, 7.8) | 7.3 | (6.8, 7.8) | 0.022 |
| Insulin treatment | 289 | (31.3) | 102 | (49.8) | 0.383 | 101 | (49.3) | 102 | (49.8) | 0.010 |
Data are median (interquartile range) or n (%).GLP‐1RA, glucagon‐like peptide‐1 receptor agonist; HbA1c, glycated hemoglobin.